Please login to the form below

patient enrolment

This page shows the latest patient enrolment news and features for those working in and with pharma, biotech and healthcare.

Entering the era of digital trials

At the same time, the data explosion and emergence of automated analytical tools have raised expectations that the industry can crack the patient enrolment conundrum and other persistent problems. ... It is at this stage in the process that smartphone

Latest news

Viking throws down gauntlet in NASH battle

The caveat of course is that the two trials have different enrolment criteria and patient baseline characteristics – in fact Madrigal’s trial was much bigger with around 150 patients versus
Merck suspends two Keytruda trials after patient deaths

Investigators to look at Keytruda with Pomalyst and Revlimid. Merck &Co has paused patient enrolment in two trials of Keytruda to allow investigators to explore reports of deaths among patients taking
Trials of AZ's durvalumab restart as FDA hold is relaxed

Patient recruitment can restart in two trials of AstraZeneca's PD-L1 inhibitor durvalumab placed under temporary suspension by the FDA, says the company. ... The phase III KESTREL trial has already re-opened for new patient enrolment at some clinical
Clinical trials enter the genomic age

Every day, a gigantic amount of genomic information is generated and analysed to identify pathogenic mutations in patient DNA. ... However, the production and analysis of patient genomic profiles is only the first part of the Data-Driven Medicine story.
FDA panel says no to quick approval of Clovis' rociletinib

Patient enrolment for the trial is expected to complete in late 2018.

More from news
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest Intelligence

Streamlining clinical trials – why better data use is key

Investment in patient enrolment and fulfilling compliance requirements are likely to remain staples of clinical drug trials – and for good reason. ... endpoints and patient safety, which can lead to better data, faster enrolment and reduced patient
The trials and tribulations of rare opportunities

Patient eligibility criteria can also impact patient enrolment. “When studying potential disease-modifying therapies, there is often a desire from study sponsors to enroll patients in the early stages of the ... Patient-centricity is also core to
Making digital health personal

The reasons for non-adherence among patients entering the programme were captured at enrolment via a patient survey (eg concerns about potential side effects, difficulties with routines). ... However, it is possible to carefully navigate the regulatory

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

How to break down the barriers to patient enrolment

In the final instalment, we look at one the biggest hurdles to successful patient support programme s: patient enrolment. ... of the patient support programme, and explain how to easily enrol their patients.Our top tips on activating the sales force
Enablers of drug innovation could lie in the numbers

trials industry estimates that 80% of clinical trials are delayed by at least one month because of unfulfilled enrolment numbers, and that patient recruitment delays account for, on average, 4.6 ... help position research centres so as to increase the

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Vice President: Competitive Salary Offered

Account Manager– Medical Communications: (Negotiable - depending on experience)

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Senior Medical Writer, MedComms Agency: Salary TBC

Consultant: competitive salary

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Director or Senior Account Director: Salary TBC

Subscribe to our email news alerts

No results were found

PMHub

Add my company

dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

A snapshot of Congenica: PME talks to CEO David Atkins...
Data desires: What are you looking to achieve with data and how are you preparing yourself to react to the results?...
The balancing act that’s keeping pharma and biotech market access on its toes: Pricing drugs and gaining reimbursement can be a real challenge for drug developers. Price it too high, and no one buys it. Price it too low, and it’s hard to...